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Abstract: Biosensing strategies that employ readily adaptable materials for different analytes, can
be miniaturized into needle electrode form, and function in bodily fluids represent a significant
step toward the development of clinically relevant in vitro and in vivo sensors. In this work,
a general scheme for 1st generation amperometric biosensors involving layer-by-layer electrode
modification with enzyme-doped xerogels, electrochemically-deposited polymer, and polyurethane
semi-permeable membranes is shown to achieve these goals. With minor modifications to these
materials, sensors representing potential point-of-care medical tools are demonstrated to be sensitive
and selective for a number of conditions. The potential for bedside measurements or continuous
monitoring of analytes may offer faster and more accurate clinical diagnoses for diseases such as
diabetes (glucose), preeclampsia (uric acid), galactosemia (galactose), xanthinuria (xanthine), and
sepsis (lactate). For the specific diagnostic application, the sensing schemes have been miniaturized
to wire electrodes and/or demonstrated as functional in synthetic urine or blood serum. Signal
enhancement through the incorporation of platinum nanoparticle film in the scheme offers additional
design control within the sensing scheme. The presented sensing strategy has the potential to
be applied to any disease that has a related biomolecule and corresponding oxidase enzyme and
represents rare, adaptable, sensing capabilities.
Keywords: biosensors; biomedical; in vitro; in vivo; needle electrode; wire; sepsis; enzyme; electrochemical;
platinum black; bodily fluids
1. Introduction
Biosensors continue to be of significant interest to the scientific community due to their importance
in a variety of fields and applications [1–5]. In the field of medicine, the development of sensors
that detect molecules that can indicate the presence or progression of a specific disease remains of
particular interest [2,6,7]. Identifying clinically relevant analytes of this nature represents an important
technological advancement toward development of in vivo devices capable of continuous, real-time
monitoring or in vitro diagnostic tools that can be quickly administered at the bedside on small
samples of a patient’s blood or urine [8–11]. In both cases, effective sensors would provide diagnostic
information for physicians at a critical juncture and allow for more effective treatment to be administered
more quickly. Biosensors must meet certain performance criteria to be considered effective including
an ability to selectively detect a specific compound within a relevant matrix (e.g., specific bodily
fluid), sensitivity to provide adequate signal-to-noise (S/N), fast response times, and the propensity for
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microfabrication into small, mass-produced, and easily used devices [12]. While presenting a powerful
diagnostic and monitoring tool for clinicians, the research and development of strategies and materials
for constructing these devices introduces a number of challenging issues at the interface of analytical
chemistry and materials science [13].
A number of individual target molecules with links to medical diagnostics or implications for
specific disease conditions are known and several examples are discussed herein. Glucose remains
one of the most studied molecules for biosensors as it is critical for diabetes management [8]. Other
clinically relevant analytes with existing bodies of literature include uric acid (UA) [14], galactose [15],
xanthine [16], sarcosine [17], cholesterol [18] and lactate (Lac) [19]. Briefly, abnormal uric acid (UA)
levels have been linked to many diseases such as gout and Lesch–Nyhan syndrome; while, more
specifically, hyperuricemia is a known indicator of pregnancy-induced hypertension (PIH), a condition
that can lead to a dangerous disorder called preeclampsia that poses significant health risks for both
mother and child [14,20,21]. The presence of galactose in newborns serves as a primary marker for
galactosemia, a potentially lethal autosomal recessive disorder [22,23]. High concentrations of xanthine
in urine correspond to a hereditary condition called xanthinuria that can lead to renal failure and
kidney stones [16]. Increased levels of sarcosine have been reported as an indicator for prostate cancer
that is more reliable than traditional prostate-specific antigen (PSA) testing [24,25]. Sepsis, the body’s
extreme and toxic response to infection, represents a continuing problem across the medical field
as the condition is often undiagnosed or misdiagnosed by physicians, resulting in nearly 6 million
deaths world-wide each year [26–28]. A 2004 case study from Nguyen and coworkers [29] identified
lactate clearance as a predictive parameter for sepsis progression, which could allow for more accurate
diagnosis and early intervention. In all these examples, the diagnostic molecules indicative of the
disease or condition also have an associated enzymatic oxidation reaction for their metabolism.
Electrochemical biosensors, more specifically, 1st generation amperometric biosensors, represent a
type of sensing platform that offers a number of the desired attributes for these biomedical sensors [30].
First, these biosensing schemes achieve selectivity because they harness enzymatic reactions at
electrodes, detecting the analyte indirectly via the oxidation of hydrogen peroxide (H2O2), a natural
by-product of the enzyme-catalyzed reaction between the target substrate and oxygen—a relatively




First generation amperometric biosensors are pursued for medical applications because they
also offer affordability, simplicity, and, in theory, are amenable to miniaturization [6,7] As such,
researchers have explored a plethora of customized 1st generation amperometric biosensing schemes
targeting clinically relevant molecules and examples in the literature are plentiful. While the reports
are numerous, it is import to note that each scheme is typically elaborately designed for a particular
analyte and most often constructed at a macroelectrode platform with the reported potential to
eventually miniaturize the scheme to a microelectrode, though actual transition to the smaller platform
is often only theoretically envisioned in many of the studies [1,2,4,32,33]. The demonstration of the
functionality of a sensing scheme after being scaled down is a critical research milestone toward
realizing effective in vivo implants or in vitro devices. In the former case, smaller sensor size allows
for minimizing inflammatory response to a foreign material, thereby improving biocompatibility [34].
Sensors miniaturized to a scale of less than 0.5 mm, smaller than the typical size of syringe needles and
catheters, are of particular interest [34–36]. Miniaturized biosensing schemes must retain the sensitivity
and selectivity effectiveness demonstrated on macroelectrode platforms—a non-trivial objective.
Other critical elements employed in the construction of such sensors is the methodology and
materials used to immobilize the enzyme at the electrode surface. One strategy for sensor design
that has emerged involves modifying the electrode with multiple layers of functional materials in
what is known as layer-by-layer (LbL) methodology [37,38]. While numerous materials such as
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electropolymers [39], hydrogels [40] and nanoporous gold [41], for example, have been exploited for
this purpose, a seminal report by Bright and coworkers in 1994 examined an LbL scheme incorporating
solution–gel (sol–gel) materials as a functional component of a glucose biosensor [42]. Sol–gels are
networks of polymerized silanes that provide a three-dimensional scaffolding for multi-layers of
immobilized enzyme at an electrode, forming a xerogel with solvent evaporation [43]. Enzyme
microencapsulation within xerogel matrices yields several well-established advantages, including
mild synthetic conditions preserving the structure and function of the embedded enzymes, chemical
inertness, physical rigidity, negligible swelling in aqueous solutions, thermal/photochemical stability,
and synthetically tunable porosity, a property of particular interest for biosensing structures [44].
Prior work in our own group has explored LbL construction of xerogel films as part of 1st generation
amperometric biosensors for glucose [3,45], uric acid [12] and galactose [22]—all on macroelectrode
platforms. While these systems were all robust in performance and, in some cases, demonstrated
the use of nanoparticle networks to enhance signal [45,46], we noted that they employed similar LbL
methods and materials. The similarity in the approaches suggested that it might be possible to present
a general strategy and set of materials as a type of template. This general template would allow for
targeting a number of different compounds with only minor adaptions of the layers and a scheme
amenable to both miniaturization to microelectrodes and operation in relevant bodily fluids (Scheme 1).
Sensors 2019, 19, x 3 of 27 
 3
this purpose, a seminal report by Bright and coworkers in 1994 examined an LbL scheme 
incorporating solution–gel (sol–gel) materials as a functional component of a glucose biosensor [42]. 
Sol–gels are networks of polymerized silanes that provide a three-dimensional scaffolding for multi-
layers of immobilized enzyme at an electrode, forming a xerogel with solvent evaporation [43]. 
Enzyme microencapsulation within xerogel matrices yields several well-established advantages, 
including mild synthetic conditions preserving the structure and function of the embedded enzymes, 
chemical inertness, physical rigidity, negligible swelling in aqueous solutions, thermal/photochemical 
stability, and synthetically tunable porosity, a property of particular interest for biosensing  
structures [44]. Prior work in our own group has explored LbL construction of xerogel films as part 
of 1st generation amperometric biosensors for glucose [3,45], uric acid [12] and galactose [22] – all on 
macroelectrode platforms. While these systems were all robust in performance and, in some cases, 
demonstrated the use of nanoparticle networks to enhance signal [45,46], we noted that they 
employed similar LbL methods and materials. The similarity in the approaches suggested that it 
might be possible to present a general strategy and set of materials as a type of template. This general 
template would allow for targeting a number of different compounds with only minor adaptions of 
the layers and a scheme amenable to both miniaturization to microelectrodes and operation in 
relevant bodily fluids (Scheme I).  
 
Scheme I. Schematic representation of strategy for biosensor development for medical 
applications. 
In this work, we explore a general template for the LbL construction of xerogel-based 1st 
generation amperometric biosensors on needle microelectrodes that are able to target multiple 
disease-related analytes within the bodily fluids most relevant for the particular disease marker. 
While some prior work in this area has demonstrated the miniaturization of LbL systems containing 
enzyme-doped xerogel schemes onto needle-type electrodes [34,36,47–50], those designs are specific 
for a singular analyte and do not investigate a versatile strategy to be used for multiple target species 
with only moderate adaptations. Herein, we demonstrate the successful adaptations of both known 
and previously unreported LbL xerogel systems to needle-type electrodes and show their 
functionality in relevant bodily fluids. The incorporation of nanoparticle films within the same 
Scheme 1. Schematic representation of strategy for biosensor development for medical applications.
In this work, we explore a general template for the LbL construction of xerogel-based 1st generation
amperometric biosensors on needle microelectrodes that are able to target multiple disease-related
analytes within the bodily fluids most relevant for the particular disease marker. While some prior work
in this area has demonstrated the miniaturization of LbL systems containing enzyme-doped xerogel
schemes onto needle-type electrodes [34,36,47–50], those designs are specific for a singular analyte
and do not investigate a versatile strategy to be used for multiple target species with only moderate
adaptations. Herein, we demonstrate the successful adaptations of both known and previously
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unreported LbL xerogel systems to needle-type electrodes and show their functionality in relevant
bodily fluids. The incorporation of nanoparticle films within the same general sensing scheme at the
needle electrodes is also explored as a means to enhance amperometric signal. While we were able to
demonstrate these abilities with a number of different systems shown in Scheme 1, we continue to use
glucose and glucose oxidase as a model system while also highlighting two previously unreported
systems, lactate and xanthine detection, to illustrate the adaptability of the template. While many
reports highlight the use of sol-gel materials [44], LbL approaches [37,38] and/or nanomaterials [1,13,32]
in the sensing of a particular analyte, the systematic expansion of a general scheme to multiple targets
is rarer. The demonstrated versatility and functionality of the presented biosensors both adapted to
wire electrodes and operational in relevant biological matrices, represents important steps toward the
realization of bioanalytical sensors capable of continuous in vitro clinical measurements, as well as
future devices with in vivo capability.
2. Experimental Details
2.1. Materials and Instrumentation
Unless otherwise stated, all chemicals were reagent grade or higher and purchased from
Millipore-Sigma (Burlington, MA, USA). Tecoflex SG-80A polyurethane (TPU) and Hydrothane
AL25-80A polyurethane (HPU) were obtained from Lubrizol (Wickliffe, OH, USA) and AdvanSource
Biomaterials (Wilmington, MA, USA), respectively. A platinizing solution (3% chloroplatinic acid,
v/v in water) was purchased from Lab-Chem (Pittsburgh, PA, USA). Synthetic urine (Surine) was
obtained from Cerilliant (Sigma-Aldrich) and blood serum (sheep) from Hemostat (Dixon, CA, USA).
All other solutions were made with 18 MΩ·cm ultra-purified water (UP H2O) (PureLab-Ultra, Elga,
High Wycombe, UK). Teflon (PTFE)-coated platinum:iridium (70:30) wire (Sigmund-Cohn, Medwire,
Mt. Vernon, NY, USA) with a diameter of 245 µm (330 µm coated) or pure platinum wire (A-M Systems,
Sequim, WA, USA) with a diameter of 127 µm (203 µm coated) were used as wire working electrodes
(WE) while 2 mm diameter (CH Instruments, Austin, TX, USA) platinum electrodes served as
macroelectrode WEs. In either case, the analytical performance of the sensors were evaluated via
amperometric current–time (I–t) curves recorded on 8-channel potentiostats (CH Instruments, 1000B
or 1030C) or a single channel potentiostat (CH Instruments, 420B). Electrochemistry was measured
versus a common Ag/AgCl (saturated KCl) aqueous reference electrode (RE) (CH Instruments) and
platinum wire counter electrode. Silanes for xerogel fabrication were purchased from Sigma-Aldrich
(octyl-trimethoxysilane (OTMS), isobutyl-trimethoxysilane (IBTMS), amino-propyl-trimethoxysilane
(APTMS), 3-mercaptopropyl-trimethoxy silane (MPTMS)) or from Gelest, Inc. (Morrisville, PA, USA),
hydroxymethyl-triethoxysilane (HMTES)) and were stored in a desiccated glovebox (Plas Labs, Inc.,
Lansing, MI, USA) and transported using sealed/desiccated microcentrifuge tubes to exclude moisture
until deposition of the material as a film. Silane bottles were replaced every 3–4 weeks in case of
inadvertent hydrolysis.
2.2. Enzymes
Glucose oxidase (Aspergillus niger), galactose oxidase (Dactylium dendroides), and xanthine oxidase
(bovine milk) were purchased from Millipore-Sigma. Urate oxidase or uricase from Bacillus fastidiosus
was purchased from Millipore-Sigma or produced in-house [12] as previously described, Additional
uricase (Candida utilis, recombinant), lactate oxidase (Pediococcus sp.), and xanthine oxidase (native
microorganisms) was purchased from Creative Enzymes® (Shirley, NY, USA).
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2.3. Fabrication of Layered Sol-gel Based Wire Biosensors
A ~5 cm length of PTFE-insulated Pt-Ir wire was cut and ~4 mm of the end exposed by
removal of the PTFE coating to create the WEs. The bare sensor was electrochemically cleaned
via cyclic voltammetry (−0.25 to +1.20 V, 0.25 V s−1) in 0.1 M H2SO4 until the voltammetry was
representative of a clean platinum surface. After cleaning, wire WEs were modified via specific but
similar procedures depending on their intended targets. The following example for the glucose model
system is provided, with additional details of similar procedures for the other sensors provided in the
Supplementary Materials.
In brief, for the glucose biosensors on wire electrodes, glucose oxidase (GOx) doped sol-gels
of OTMS were formed by first dissolving 9.0 mg of GOx in 75 µL of UP H2O in a centrifugation
vial and, in a separate vial, diluting 25 µL of OTMS with 100 µL of tetrahydrofuran (THF). These
vials were sealed and hand-vortexed vigorously for 5 min and 1 min, respectively. After individual
mixing, 50 µL of the GOx/H2O solution was transferred to the OTMS/THF mixture and shaken for an
additional 1 min to facilitate the formation of a sol−gel. The process of deposition of the sol-gel onto
the wire electrode was adapted from Schoenfisch et al [47], coating with the GOx precursor solution
by dip-coating the sensor five times (5 s submerged time, 10 s dry period under ambient conditions).
The electrodes were then dried horizontally for 30 min at 50% RH (relative humidity) before the next
sol–gel deposition. The second layer of sol–gel was prepared as above with the omission of GOx,
following the same dip-coating procedure to provide a diffusion-limiting layer. Unless otherwise
stated, sol−gel coated electrodes were allowed to form xerogels over 48 h inside a temperature/50%
relative humidity (RH) controlled chamber (Cole-Parmer, Vernon Hills, IL, USA) [45,51]. Notice: Strict
RH control, through the use of desiccated glove boxes/vessels during storage/handling of silanes as
well as with a humidity-controlled chamber during deposition/drying of the sol−gels was found to be
critical for consistent sensor performance [45].
After application of the sol-gel layers, an additional polymer layer was added. For example,
for glucose sensing, a polyphenol layer was applied to assist the selectivity of the sensors [47,52,53].
A solution of phenol was prepared (25 mL, 40 mM) with 60 mM PBS at pH = 7.4, degassed with N2 for
20 min and electropolymerized onto the wire sensor by chronocoulometry (held at +0.9 V for 15 min
while stirring). Sensors were rinsed with UP H2O and allowed to dry horizontally for 30 min at 50% RH.
An outer polyurethane (PU) layer was then deposited in order to limit diffusion and improve glucose
selectivity [45,47]. A 50:50 PU blend of hydrophilic HPU and hydrophobic TPU was prepared by
adding 50 mg of HPU and TPU each to a 5 mL solution of THF/EtOH (50:50 v/v) and stirred overnight.
The PU was dip-coated on the wire electrodes for 10 cycles as described above and were allowed to
dry for 30 min horizontally at 50% RH. The tip of the sensor was capped with epoxy and allowed to
dry for 45 min at 50% RH, resulting in a 3–4 mm sensing pseudo-cavity. A similar detailed procedure
for the other biosensors can be found in the Supplementary Materials, including uric acid, lactate,
and galactose, for examples. Additionally, fabrication of the sensors on macroelectrodes proceeded in
a similar fashion with the exception that prior to electrochemical cycling to clean the electrode, the
macroelectrodes were polished with successively smaller alumina on a polishing wheel and rinsed
with copious amounts of water [3].
2.4. Platinum Black Modification of Wire Electrodes
Prior to sol–gel deposition, cleaned bare electrodes were platinized in 3% chloroplatinic acid
(v/v in water) by cycling the potential from +0.6 to −0.35 V at a sweep rate of 20 mV s−1 to obtain
a Pt-B-modified platinum working electrode [46,54]. The Pt-B-modified surface was assessed using
scanning electron microscopy (SEM) imaging and surface area was calculated with well-established
chronocoulometry methodology [55,56].
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2.5. Evaluation of Biosensor Performance
Completed sensors were soaked in 60 mM potassium phosphate buffer solution (PBS) at pH 7.4
for a minimum of 1 h to reduce current drift and impregnate the sol−gel with buffer solution. Most
biosensors were subjected to +0.65 V in 25 mL of PBS for at least 20 min prior to injection of any
substrate/analyte to stabilize sensor reading. Sensors were calibrated by adding successive injections
of increasing concentrations of substrate.
3. Results and Discussion
The basic design of the biosensing scheme includes some combination of four layers of electrode
modification: (1) an enzyme-encapsulating xerogel layer, (2) an undoped xerogel (diffusional layer),
(3) an inner selective electrochemically-deposited polymer layer, and (4) a multi-functional ad-layer of
polyurethane (Figure 1A) [3,12]. Each of the layers had been previously characterized and studied
for their properties, including entire reports on electrochemically-deposited polymer films and work
establishing that the xerogel porosity was controllable based on moisture content, aging time, and
silane precursor. Moreover, specific combinations of this type of layering were previously investigated
and optimized for the detection of target analytes at the macroelectrode surfaces, including successful
glucose [3], uric acid [12] and galactose [22] biosensors. In those studies, it was shown that each layer
serves a specific and functional purpose, whether enhancing sensitivity, improving selectivity against
interferents, or preventing enzyme leakage. The challenge of the current study was to successfully
transition this scheme to needle electrodes while showing it to be versatile enough to be applied to a
number of different targets, including some systems not previously explored. Additionally, as part of
the scheme’s versatility, signal enhancement strategies using nanoparticle films were explored as an
option for the scheme and operational viability in relevant bodily fluids was also investigated. With
these goals, however, it is important to note that one must consider the ultimate sensing goals for a
particular system. For example, while miniaturization might be useful for in vivo device development
(e.g., continuous, real-time implant for lactate measurements), it may not be necessary for some in vitro
applications (e.g., sarcosine prostate cancer screening or galactose testing for galatosemia testing).
Similarly, operation in specific bodily fluids may be more important for specific analytes compared to
others. If the target is expected to be present in urine, it is unnecessary to show operational viability
for detection of the species in other matrices (e.g., blood serum). It is with these considerations that the
following studies were conducted. However, as in prior studies [45] and given its affordability and
availability, the glucose/glucose oxidase (GOx) system continued to serve as a practical target/enzyme
model system for initial, proof-of-concept experiments.
3.1. Miniaturization of Model Scheme onto Needle-Type Electrode
Miniaturization of a biosensor presents a challenge in that, as one significantly changes the size and
shape of the transducer, there is no guarantee that the sensing response achieved on macroelectrodes
will be effective on a smaller platform with different geometry. The LbL strategy using xerogel materials
was employed to construct sensors at the miniaturized electrochemical interface of the exposed tip of a
Teflon-coated platinum wire (Figure 1B). In transitioning these sensing systems to a wire geometry with
a diameter in the range of 120–250 µm, a small area at the end of the coated platinum wire (<3–4 mm)
was first exposed via removal of the Teflon coating, electrochemically cleaned, and subsequently
modified as shown in Figure 1A. In this study, for proof-of-concept operation of these sensors at the
wires, an epoxy cap at the tip of the wire was used to form a pseudo sensing cavity where the film
was constructed and minimize sensing irregularities that might arise from the otherwise exposed
and irregular geometry of the cross-section of the wire’s tip (Figure 1B). Once films were formed
in the pseudo cavities, the wire-based sensors were evaluated on sensing performance similar to
macroelectrode systems, including measurements of sensitivity, response time, and selectivity.
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Figure 2. (A) Typical amperometric I-t response and corresponding calibration curve (inset) during
successive 1 mM injections of glucose at a (a) Pt wire electrode, (b) Pt-Ir wire electrode, and (c) Pt
macroelectrode modified with GOx-doped OTMS xerogel, undoped OTMS xerogel, polyphenol (PP),
polyurethane layer (50:50), and epoxy cap; (B) Typical amperometric I-t response and (C) calculated
selectivity coefficients during successive injections of common interferent species (100 µM) and glucose
(1 mM and/or 3 mM) at a Pt-Ir wire electrode modified with the same four layers described in (A).
Notes: Soln. is 60.0 mM PBS, pH = 7.4, µ = 155 mM (wires) and 4.4 mM PBS, pH = 7.0 (macroelectrode).
Note: Error bars represent standard error (n ≥ 3).
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A significant challenge of most biosensor designs is achieving sufficient sensitivity while simultaneously
discriminating against common interferent species. Both the electrochemically-deposited polymer and
PU layers have been previously shown to aid in selectivity and were similarly incorporated within the
miniaturized glucose sensing scheme and tested for interferent response [3,57]. Figure 2B shows an I-t
curve of the same OTMS xerogel systems on platinum-iridium wire (d = 245 µm) electrodes capped with
both polyphenol and 50:50 PU designed for glucose sensing during injections of common interferents
(i.e., acetaminophen, ascorbic acid (AA), sodium nitrite, oxalic acid, and uric acid) as well as standard
glucose injections of different concentrations. As seen in Figure 2B, current responses from the injection of
endogenous physiological interferents are nearly negligible compared to those of the glucose injections.
Only acetaminophen registers a significant measurable response and, while this represents a challenge,
it is important to remember that acetaminophen is a synthetic pharmaceutical that is ingested and clears
the body in a relatively short time (4–6 h). Thus, in any eventual medical application of these sensors,
the presence of acetaminophen should be identifiable with an effective patient history [55]. Selectivity
coefficients (Kamp) were calculated to conservatively and quantitatively assess selectivity as has been done






where ∆Ij and ∆Ig are the measured currents for a specific interferent species (j) and glucose and Cj and Cg
are concentrations of the interferent species and glucose, respectively. Negative values of Kamp indicate
that the interferent is inconsequential (i.e., no significant response compared to analyte response) whereas
species with near zero or positive values are selected for by the sensor. In this case, the magnitude of
the Kamp values (Figure 2C) suggest excellent discriminatory selectivity of the sensing scheme even at a
miniaturized interface. A similar I-t curve establishing selectivity against most interferent species was
achieved at the smaller platinum wires as well (Supplementary Materials, Figure SM-1).
It is important to note that the mechanical removal of the wire coating and subsequent application
of the epoxy cap to the tip of the wire results in a variable electroactive surface area for each sensor.
As such, the model glucose system was used to confirm that this variation in area does not affect the
overall response linearity of these miniaturized sensors. The electrochemical determination of individual
wire areas allows for a comparison of a current response versus a current density response at the wire
electrodes. Specifically, chronocoulometry of potassium ferricyanide at the wire electrode was used to
assess the electroactive surface area of the pseudo cavity prior to modification and normalize current
response to electrode area [24]. An example of the chronocoulometric analysis for electroactive surface
area is shown in the Supplementary Materials (Figure SM-2). Linearity in the calibration curves between
0 and 12 mM glucose was maintained regardless of area standardization (Supplementary Materials, Figure
SM-3) demonstrates the dependability of the scheme design despite wire-to-wire geometrical variations.
Based on this result, with regard to the wire microelectrodes, the remainder of our study herein was
conducted exclusively with the platinum-iridium wires with a bare diameter of 245 µm.
3.2. Versatility of Scheme for Multiple Analytes at Needle-Type Electrodes
As previously mentioned, most biosensing schemes found in literature reports are elaborately
constructed to target a single analyte and cannot be easily adapted to a different target. A major
proposed advantage of the strategy and materials utilized with the presented scheme is that it can be
readily adapted to both a wire geometry and a variety of different analytes. For this study, adaptations
of the four-layer scheme (Figure 1A) previously reported only at macroelectrodes were transitioned to
wire electrodes while new, previously unreported systems were also targeted for adaptation to wires.
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3.2.1. Uric Acid and Galactose Biosensors
Elevated levels of uric acid (UA) or hyperuricemia can serve as a reliable diagnostic marker for
pregnancy-induced hypertension (PIH), a disorder that can lead to a more serious, life-threatening,
condition called pre-eclampsia [12]. A uric acid biosensor, particularly one that can be miniaturized
for potential real-time measurement devices would allow for faster and more accurate diagnosis
of patients at risk for these complications. Wire electrodes were modified with uricase (UOx)
doped HMTES xerogel, followed by an undoped layer of HMTES and subsequently capped with a
polyluminol-polyaniline (PL-A) electrochemically-deposited polymer layer and polyurethane (100%
HPU), the same layering strategy successfully applied to macroelectrodes in a previous study [3,47].
As shown in Figure 3A, the modified as described wires exhibited a robust stair-step response to
increasing concentrations of uric acid and produced a calibration curve with linearity through the
relevant physiological range (100 to 600 µM). As in with the glucose model system, the uric acid wire
sensors reported excellent discrimination against common, naturally occurring interferent species
(Figure 3B,C). Only acetaminophen results in a significant current response and again, as an artificial
interferent whose consumption can be reported by patients, presents less of a concern than other species.
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A similar successful transition to wire electrodes was achieved for LbL-constructed galactose
biosensor that was recently reported at macroelectrodes [22]. Accurate galactose measurements in
newborns can predict the presence of the disorder galactosemia [23]. Based on the prior report at
macroelectrodes [22] wire electrodes were modified with GaOx-doped IBTMS xerogel, a 50:50 PU layer
and an epoxy cap (Figure 1A). As with the UA adaptation, a stair-step amperometric I-t response was
achieved and translated to a linear calibration curve with a physiologically relevant linear range up to
7 mM galactose and fast response times (Supplementary Materials, Figure SM-4). In both cases, UA
and galactose biosensing, comparisons of the sensor performance with literature reports of sensors for
the same targets can be found in the original studies [12,22].
3.2.2. Xanthine Biosensors
While the previously presented results focus on systems that were previously established at
macroelectrodes, it was also of interest to see if the strategy and materials could be adapted to previously
unreported and more complex systems. The detection of xanthine is critical for diagnosing xanthinuria
in humans and can also serve as an indicator for potential hand-held sensors able to detect spoiled
meat and fish [16]. In terms of biosensing, xanthine presents a unique situation for a LbL system given
the enzymatic reaction of xanthine oxidase (XOx) with the xanthine produces H2O2 and uric acid
(UA)—the ratio of which is dependent on the amount of oxygen present: [58].
Xanthine + O2 Xox→ H2O2+uric acid (3)
The products are important in this case because both are electroactive and will be oxidized at
an electrode held at the typical +0.65 V. In order to apply our materials and LbL strategy, it is critical
to first completely understand the components of the amperometric signal observed. As such, when
both H2O2 and UA are directly injected at an electrode poised at +0.65V they each yield a significant
amperometric response (Supplementary Materials, Figure SM-5A). However, if the potential is held at
+0.35 V, H2O2 oxidation is observed while the UA oxidation is selectively eliminated (Supplementary
Materials, Figure SM-5B). A similar experiment was conducted with XOx-doped PTMS xerogel and
capped with PU (100% HPU) and subjected to injections of xanthine. At an electrode held at +0.65 V,
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the injections of xanthine result in a stair-step response, which is attributed to both H2O2 and UA
oxidation. The presence of both species is confirmed with the injection of a significant amount (1 µM)
of catalase, an enzyme that consumes H2O2. The catalase injection causes an abrupt decrease in current
but does not return the amperometric response to baseline, suggesting the continuing presence of
UA product in the solution. However, if the signal from UA is turned off by applying a potential of
+0.35 V as to isolate only the H2O2 oxidation, a similar, but significantly smaller stair-step response
is observed. In this case, injection of catalase returns the signal nearly to baseline (Supplementary
Materials, Figure SM-6). In this manner, we can stabilize xanthine sensing response by understanding
and controlling the species creating the analytical signal.
Prior to testing on wire electrodes, and as with other systems tested, the four-layer scheme
(Figure 1A) was first applied to a platinum macroelectrode platform. Platinum electrodes modified
with XOx-doped PTMS xerogel and PU capping layer (100% HPU) were tested for xanthine sensitivity
and selectivity. A typical I-t curve during xanthine injections and the corresponding calibration curve,
which easily spans the relevant physiological range (0–100 µM) shows that the system is sensitive for the
detection of xanthine. Similarly, the amperometric response during interferent and xanthine injections,
along with corresponding calculated selectivity coefficients, support that the adaptation to xanthine is
also produces selective response (Supplementary Materials, Figure SM-7). The performance of the
xanthine sensor is comparable to reports in the literature for other xanthine sensing systems [59–65]
compiled and provided in Supplementary Materials (Table SM-1).
With the verified ability to differentiate UA response from H2O2 signal via the applied voltage, the
system was readily adapted to wire electrodes. The same materials comprising the composite film at
the macroelectrode were applied to the wire electrode with the results shown in Figure 4. The films
at wire electrodes, though exhibiting an expectedly lower current response, showed definitive stair-step
responsiveness toward xanthine injections, a substantial linear range, and similar response time (Figure 4A).
Selectivity toward xanthine was largely maintained at the wire electrode (Figure 4B,C) though the
different electrode geometry appears to allow for a greater AA interferent response compared to the
macroelectrode system—a result suggesting that future research efforts may focus on identifying an
appropriate electrochemically-deposited polymer film to exclude that particular species [53]. While the
rigorous measurement of selectivity coefficients for the modified wire electrode (Figure 4C) suggests that
sodium nitrite (NaNO2) is registering a substantial interferent response, particularly compared to the
macroelectrode system (Supplementary Materials, Figure SM-7B), we note from the actual and typical I-t
response at the wire (shown in (Figure 4B) that there is no significant signal generated upon injection of
NaNO2. These results suggest that the selectivity coefficient for NaNO2 is likely artificially inflated due to
the rising background current observed after the substantial AA response.
3.2.3. Lactate Biosensors
One of the most consequential developments of our strategy and scheme would be an adaptation to
lactate detection as it relates to tools for sepsis diagnosis and monitoring. Sepsis is a systemic response
of a body to serious infection. In the U.S. alone, more than 1.5 million people get sepsis every year [27],
resulting in approximately 250,000 deaths (5000 children’s deaths) [66], while worldwide, an estimated
30 million people contract the condition [67] including 6 million newborns [28]. One in three patients in
the United States who develops sepsis will die in the hospital from the condition—making it the leading
cause of deaths in hospitals in this country [27]. Accurate diagnosis of sepsis and early intervention at
the emergency room with broad spectrum antibiotics, intravenous fluids, and, if possible, bacterial
specific antibiotics (after blood testing) represent life saving measures. Unfortunately, sepsis is often
undetected or commonly misdiagnosed and, if untreated, very quickly transitions from general sepsis
to severe sepsis and eventually to septic shock where corresponding tissue hypoxia and organ failure
render a >50% mortality rate [27–29]. A number of recent cases in the news have illustrated the danger
of misdiagnosis with sepsis. The 2012 case of Rory Staunton, a 12-year-old boy who developed sepsis
after getting a cut at his gym and died only 3 days later, has increased awareness of sepsis through
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The Rory Staunton Foundation for Sepsis Prevention but also continuously updates with victims of
sepsis [68]. Additional sepsis cases have recently received high media attention, including the death
of a 29-year-old mother of seven after a minor skin infection [69] and a 31-year-old man succumbing
to sepsis after swimming with a new tattoo [70]. In very recent news, Jakelin Maquin, age 7, died of
septic shock while in the custody of the U.S. Border Patrol [71].
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10 µM injections of xanthine at a Pt-Ir wire electrode (+0.35V) modified with XOx-doped PTMS
xerogels, polyurethane layer (100% HPU), and epoxy cap. (B) Typical amperometric I-t response and
(C) calculated selectivity coefficients during successive injections of common interferent species (40 µM
and/or 100 µM) and xanthine (10 µM and/or 30 µM) at a Pt-Ir wire electrode (+0.35V) modified as in (A);
Solution: 60.0 mM PBS, pH = 7.4, µ = 155 mM. Note: The error bars represent standard error (n ≥ 10).
Sensors 2019, 19, 2584 14 of 25
Current sepsis diagnosis procedures still primarily rely on physical examination (e.g., fever, heart
rate, breathing), which is prone to misdiagnosis as a flu-like illness, or time-consuming laboratory
tests (e.g. X-ray, blood and urine analyses) during which common sepsis can progress toward septic
shock with significantly increased mortality. A 2004 case study [29] identified lactate clearance (LC)
as a predictive parameter for sepsis survival where out of more than 100 patients presenting with
severe sepsis/septic shock symptoms, those with elevated LC (>10%) after 6 hours were determined to
have a significantly higher probability of survival. Patients exhibiting persistent low levels of LC were
associated with an almost 90% mortality rate. The study suggests that lactate, particularly if it could be
continuously monitored with an in vivo implantable device or a bedside in vitro quick test, may be
an effective tool for early and accurate diagnosis of sepsis, allowing physicians to administer more
effective treatment of sepsis.
As with the other systems, LbL-constructed modification of a macroelectrode in order to establish
lactate sensitivity and selectivity preceded attempts to miniaturize to wire electrodes. Pt macroelectrodes
were modified with an electropolymerized pyrrole layer as a selective membrane prior to deposition of
a HMTES xerogel co-embedded with both lactate oxidase (LOx) and bovine serum albumin (BSA),
the latter serving as a stabilizing agent as in prior reports utilizing LOx [72]. The HMTES xerogel
was capped with PU (100% HPU). The system responded to 1 mM injections of sodium lactate,
yielding the expected stair-step amperometric response typical of these systems (Supplementary
Materials, Figure SM-8A). Unlike other systems, however, the lactate sensor shows a strong initial
amperometric response during early injections of lactate before becoming more consistent and
eventually dissipating. The reasons for this inconsistency are not fully understood and it does result in
a two stage calibration curve that is linear in both the low or normal (i.e., resting) physiological lactate
concentration range (<3 mM) as well as the elevated or abnormal (>3 mM) range common to sepsis
conditions (Supplementary Materials, Figure SM-8A, inset). Interferent testing of this system was also
successful with the layered sensor showing excellent selectivity for lactate and discrimination against
all interferents except acetaminophen, the only non-naturally occurring interferent (Supplementary
Materials, Figure SM-8B). The performance of the lactate sensor is comparable to other reports in the
literature describing similar types of electrochemical sensors [39,72–80] (Supplementary Materials,
Table SM-2).
As with the other systems after successful demonstration of functionality of the LbL construction
and materials at macroelectrode platforms, it was then transitioned to wire electrodes. The adaptation
of the lactate detection scheme to a wire electrode was particularly critical given that the targeted
application could involve the insertion of a needle sensor capable of real-time lactate measurement
into the flesh of an emergency room patient as is already done with an intravenous line in current
practice. Figure 5 illustrates the successful transition of the system to the wire electrode. As with the
other systems, a fast, stair-step response with a substantial linear range is achieved prior to the onset
of Michaelis-Menton kinetic limitations (Figure 5A) [22,51]. Additionally, the film system maintains
effective selectivity toward lactate with nearly negligible responses toward major interferents, including
acetaminophen, AA, UA, and cysteine (Figure 5B), a result reinforced in the calculation of negative
selectivity coefficients for those particular interferents (Figure 5C). The successful demonstration of
the versatility of the materials and the general strategy suggests that both could readily be applied to
additional species not currently under investigation where an enzyme-catalyzed reaction metabolizes
a target molecule related to a specific molecule that is a diagnostic marker for a medical condition
(e.g., cholesterol for heart disease [18] sarcosine for early prostate cancer detection [17,24]).
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Figure 5. (A) Typical amperometric I-t response and calibration curve (inset) during successive 200 µM
injections of lactate at a Pt-Ir wire electrode (+0.65 V) modified with polypyrrole, LOx and BSA
co-doped HMTES xerogels, polyurethane layer (100% HPU), and epoxy cap. (B) Typical amperometric
I-t response and (C) calculated selectivity coefficients during successive injections of common interferent
species (100 µM) and lactate (200 µM and 400 µM) at a Pt-Ir wire electrode modified as in (A); Solution:
60.0 mM PBS, pH = 7.4, µ = 155 mM. Note: The error bars represent standard error (n ≥ 3).
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3.3. Signal Enhancement Strategies within the LbL Design
Given the established versatility of the scheme toward different analytes, it is important to note
that the proper detection of any particular target species by a sensor will be closely related to their
physiologically relevant concentration range. In some cases, detection of any significant concentration
of analyte is diagnostically significant (e.g., galactose [23], sarcosine [24]) while in other situations
the concentration ranges needing to be monitored can vary over different range (e.g., normal glucose
4–7 mM [2], normal uric acid 200–500 µM [12]). The ability to adjust sensor sensitivity toward an
analyte via the introduction of a simple tool that is also amenable to incorporation into the wire scheme
would be a distinct advantage of the LbL strategy that has been demonstrated. Additionally, in cases
where an in vivo implant for real-time monitoring of an analyte is desired, the sensor design in this
study would likely also need to be coupled to biocompatibility strategies that often include additional
layering such as NO releasing materials [81]. All additional layers of material represent a trade off in
adding functionality at the cost of depressing signal. As such, additional layers supplementing the
scheme (Figure 1A) may allow the signal enhancement needed to reach a physiological range of analyte
concentration or provide signal enhancement if used in conjunction with biocompatibility strategies.
For the wire-type electrodes in this study, it remains desirable to improve the signal without
sacrificing the miniaturization—that is, improving the electroactive or real surface area without
significantly increasing the geometric area. To achieve this, the application of an under-layer of platinum
black (Pt-B), shown previously to improve sensitivity at macroelectrodes [46] was electrochemically
applied via cyclic voltammetry to the wire systems (see Experimental). The application of Pt-B material
results in a visible change in the appearance of the wire, transitioning from a shiny metallic luster of
platinum to a black coating (Supplementary Materials, Figure SM-9). Figure 6 shows SEM imaging of
the wire and illustrates the morphology changes accompanying the modification of the wire electrode
with Pt-B, a process that both visually and experimentally, as measured with chronocoulometry
(Supplementary Materials, Figure SM-2), clearly increases the electroactive surface area without
significant change to the overall geometric area.
The Pt-B layer can be applied under the initial xerogel layer with ease and has a substantial signal
enhancement effect. Figure 7 illustrates the typical enhancement observed with the addition of the Pt-B
under-layer—shown for the glucose model system at a wire. The results clearly indicate a much more
substantial, larger current stair-step response is achieved with the use of the Pt-black under-layer—a
response that translates into a calibration curve with a substantially higher slope (i.e., higher sensitivity
toward glucose). The effect of adding Pt-B under-layer is substantial in every scheme in which
it was tested. This robust form of signal enhancement through the use of Pt nanoparticle films
was demonstrated on a number of issues, including a uric acid, LbL constructed wire electrode
(Supplementary Materials, Figure SM-10). The enhancement is anticipated to be effective for all of the
schemes presented.
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Figure 7. (A) Amperometric I-t curves and (B) corresponding calibration curves during successive
1 µM injections of glucose at a Pt-Ir wire el ctrode modified with GOx-doped OTMS xerogel, un ped
OTMS xerogel, polyphenol, polyurethane layer (50% HPU, 50% TPU), and epoxy cap both (a) with and
(b) without a Pt-black under-layer. Solution: 60.0 mM PBS, pH = 7.4, µ = 155 mM. Note: The error bars
represent standard error (n ≥ 4).
3.4. Operation of Wire Electrode Sensors in Relevant Bodily Fluids
The demonstration of these schemes and materials being operational in relevant bodily fluids is a
critical step in achieving greater versatility. While some sensors can be applied to buffered solutions,
it is important that, when necessary or applicable for a specific diagnostic, they function in systems like
blood, blood serum, or urine. As with the other forms of versatility, macroelectrodes modified with the
LbL scheme for the detection of glucose, our model system, were tested in both synthetic urine and
blood serum solutions. The stair-step amperometric response to increasing concentrations of glucose
were again evident for both types of media (Supplementary Materials, Figure SM-11). Additionally,
similar responses were achieved for LbL modification of a macro platinum electrodes designed for
either UA or xanthine detection in blood serum and synthetic urine (Supplementary Materials, Figures
SM-12, SM-13). In both cases, the background or charging current (i.e., non-Faradaic signal) was
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observed to be larger in the blood serum samples. Given the substantial presence of electrolyte and
interferent species as well as the higher viscosity of serum compared to buffered solution or synthetic
urine samples, this artifact of the results is unsurprising.
Wires were successfully modified with the same LbL films for the glucose model system and were
demonstrated to be operational in bodily fluids. For example, Figure 8A shows the amperometric I-t
stair-step response and corresponding calibration curves for the modified macroelectrode versus the
modified wire electrode in synthetic urine media. While some of the linear range is attenuated with the
wire electrode, the calibration curve is still linear through the physiologically relevant concentration
range. Additionally, the signal can be successfully enhanced in the same media with the use of a
Pt-B under-layer as part of the modified Pt-Ir wire electrode (Figure 8B). While the Pt-B increases
charging current, consistent with increased electroactive area, it clearly enhances the current in the
synthetic urine media and yields a calibration curve with a greater slope. These results suggest viability
of the system on wires and within this bodily fluid with a viable option to enhance signal with a
Pt-black under-layer. A similar result was achieved with the same system in blood serum as well
(Supplementary Materials, Figure SM-14).
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Figure 8. Amperometric I-t curves and corresponding calibration curves (insets) during successive 1
mM injections of glucose at (A) Pt macroelectrodes (a) vs. Pt-Ir wire electrodes (b) each modified with
GOx-doped OTMS xerogel, undoped OTMS xerogel, polyphenol (PP), and polyurethane layer (PU)
tested in synthetic urine; (B) The same LbL system at Pt-Ir wire electrodes (a) with and (b) without
Pt-black underlayer and tested in synthetic urine. Note: Error bars represent standard error (n ≥ 3).
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One of the most important sensing schemes to demonstrate as functional within relevant bodily
fluids is the lactate sensor as it is one of the more likely systems to eventually be developed into a
real-time, continuous measurement in vivo sensor for sepsis diagnosis. For this specific application
of the sensors clinicians would be less concerned with determining a blood concentration and more
interested in monitoring lactate clearance over time (i.e., changing concentration) [29]. LbL construction
of the LOx system was applied to wire electrodes and tested in blood serum with the results shown
in Figure 9. The stair-step response upon injection of lactate to the serum is clearly observed and
translates to a significant linear range in the calibration curve (Figure 9, inset). While gaining better
control over the charging current background remains an area of interest during further development
of these sensors, the results clearly establish the viability and promise of the overall strategy with the
successful sensing of one of the more challenging target molecules within a bodily fluid matrix.
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4. Conclusions
This work has demonstrated the high functionality and impressive adaptability of LbL film
assemblies featuring xerogel layers with immobilized enzymes with electrochemically-deposited
polymer layers and polyurethane-based selective membranes utilized for clinically relevant 1st
generation amperometic biosensors. While the primary versatility of the general sensing scheme
stems from the ability target a wide range of disease-related targets via minor modifications of the
layering material, assembly procedure, or testing parameters, it also includes adaptation of the scheme
to wire/needle electrodes, a critical step for both small sample testing at the bedside (i.e., in vitro
measurements) or continuous intravenous measurements with in vivo implants. Specifically, the wire
electrodes here have been adapted easily and effectively for the detection of five analytes including
glucose, galactose, uric acid, xanthine, and lactate implicated in their respective diseases of diabetes,
galactosemia, PIH, xanthinuria, and sepsis. The approach presented is bolstered by the option to
utilize nanomaterials to enhance signal and the demonstration that the systems remain viable in
bodily fluids. While the study focused on modifying the tip of a needle electrode which would
be easily damaged or disrupted if used in an in vivo application, the strategy and materials of the
sensing scheme should be easily amenable to a sensing cavity on the stem of beveled needles to
better protect the sensor (Supplementary Materials, Figure SM-15). Similarly, the LbL modification
schemes of the working electrodes in this report, particularly the wire electrodes, are compatible with
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established methodology incorporating an integrated reference electrode on the same wire as well
as biocompatibility strategies/materials [8,47]. The demonstrated versatility, miniaturization, and
functionality of this general sensor template sets the foundation for achieving sensors that, in theory,
can be readily adapted to a large number of clinically relevant targets and is an important advancement
toward that goal.
Supplementary Materials: The following are available online at http://www.mdpi.com/1424-8220/19/11/2584/s1,
Experimental details for fabrication and performance testing of lactate, xanthine, and uric acid sensors; Figure SM-1:
I-t curves for GOx system at different-sized wires; Figure SM-2: chronocoulometry for determining electroactive
area; Figure SM-3: I-t and calibration curves with and without area standardization (wires); Figure SM-4: I-t and
calibration curves for GaOx system at Pt-Ir wire; Figure SM-5: I-t curves for UA and H2O2 injections; Figure
SM-6: I-t curve for xanthine injections with and without catalase; Figure SM-7: I-t and calibration curves with
interferent testing for XOx system; Table SM-1: Comparison of sensing performance parameters with literature
(XOx system); Figure SM-8: I-t and calibration curves for LOx system; Table SM-2: Comparison of sensing
performance parameters with literature (LOx system); Figure SM-9: Cyclic voltammetry for Pt-black formation;
Figure SM-10: I-t and calibration curves for Pt-black effect (UOx system); Figure SM-11: I-t and calibration curves
for GOx system in blood serum and urine (wire); Figure SM-12: I-t and calibration curves for UOx system in blood
serum and urine (wire); Figure SM-13: I-t and calibration curves for XOx system in blood serum and urine; Figure
SM-14: I-t and calibration curves for GOx system in blood serum and urine (wire).
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